In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow, to talk about eConsent adoption in clinical trials. They discuss the research behind why animated, electronic consent is better perceived by patients, the fragmented technology landscape sites have to navigate, the plain-language and health-literacy challenges baked into consent forms, and the timeline and budget pressures that keep eConsent from being standard practice. They also cover why pediatric and rare disease studies could be the fastest path to wider adoption, and how reconsent, an often-overlooked, recurring part of the process, is particularly well suited to going digital.
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader & COA SME at TransPerfect Life Sciences, is joined by Katja Rudell, VP...
DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host...
In our first episode of LifeSci Talks, Global Practice Leader & COA SME of TransPerfect Life Sciences sits down with Dr. Elin Haf Davies,...
